Clinical Trials Browser

Phase 2 × Stomach Neoplasms × Olanzapine × Clear all

NCT03575637 2018-07-03

Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms